Locations
United States · Rockville, MD, USA · North America · Washington, DC, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2008
REGENXBIO is a leading clinical-stage biotechnology company focused on gene therapy, utilizing its NAV® Technology Platform to develop innovative treatments for retinal, metabolic, and neurodegenerative diseases. The company aims to deliver one-time curative therapies, leveraging over 100 novel AAV vectors and robust clinical programs, along with in-house commercial-ready manufacturing capabilities. With a strong commitment to improving patient lives, REGENXBIO is positioned at the forefront of gene therapy innovation, addressing both common and rare diseases.
Something looks off?On-site & Remote